The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR

Registration number
Ethics application status
Date submitted
Date registered
Date last updated
Type of registration
Retrospectively registered

Titles & IDs
Public title
Enhancing residential substance abuse treatment with computer interventions
Scientific title
A randomised trial of a computer-based depression intervention for individuals attending a residential substance abuse program.
Secondary ID [1] 259965 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Alcohol and substance abuse 267969 0
Depression 267970 0
Condition category
Condition code
Mental Health 268100 268100 0 0
Mental Health 268239 268239 0 0

Study type
Description of intervention(s) / exposure
Computer delivered motivational interviewing and cognitive behavioural therapy (SHADE therapy: Self-Help for Alcohol and other drug use and Depression). Individuals in this condition will complete 2 x 50 minute sessions of the SHADE program each week, over a period of 5 weeks.
Intervention code [1] 266657 0
Intervention code [2] 266779 0
Treatment: Other
Intervention code [3] 266780 0
Comparator / control treatment
A computer delivered touch typing skills program (Type Master Pro). Individuals in this condition will complete 2 x 50 minute sessions of the Type Master Pro each week, over a period of 5 weeks.
Control group

Primary outcome [1] 266848 0
Opiate Treatment Index (OTI)
Timepoint [1] 266848 0
3 months
Primary outcome [2] 266849 0
Beck Depression Inventory (BDI-II)
Timepoint [2] 266849 0
5 weeks and 3 months
Secondary outcome [1] 276496 0
Dysfunctional Attitudes Questionnaire
Timepoint [1] 276496 0
5 weeks and 3 months
Secondary outcome [2] 276497 0
Drug Taking Confidence Questionnaire (DTCQ)
Timepoint [2] 276497 0
5 weeks and 3 months
Secondary outcome [3] 276498 0
Drug Risk Response Test (DRRT)
Timepoint [3] 276498 0
5 week and 3 months
Secondary outcome [4] 276499 0
Ways of Responding (WOR)
Timepoint [4] 276499 0
5 weeks and 3 months
Secondary outcome [5] 276500 0
PENN Alcohol Cravings Questionnaire
Timepoint [5] 276500 0
5 weeks and 3 months

Key inclusion criteria
All participants attending The Salvation Army William Booth Program will be asked to participate. All participants will have an alcohol or other substance abuse disorder. Previous surveys of The Salvation Army program indicates that approximately 50% of participants report a previous mental health diagnosis.
Minimum age
18 Years
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
Significant acquired brain injury

People who's primary language is other than english

People who are acutely suicidal

Study design
Purpose of the study
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants will be in the first 3-weeks of the William Booth Program. They will complete a structured interview with a research assistant. At the completion of the interview they will be randomly allocated to one of the conditions (1) Treatment (SHADE) or (2) Active Control (Type Master Pro). .
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
All participants upon entry to the study will be given a unique numerical code. This unique code will have previously been randomly assigned a treatment allocation using a random numbers table. The treatment assignment will be written on a piece of paper, and inserted into a blank envelope with the unique participant code written on the front of the envelope. Upon completion of the
initial assessment, the participant will be asked to open the relevant envelope (the one with their unique code entered on the front) to reveal their treatment allocation. The randomisation procedure will stratify for both gender and whether the person is currently taking antidepressant
medication to ensure the proportion of males & females, and individuals with a history of depression is consistent across the two groups. Randomisation will be blocked so that the distribution of participants across treatment conditions will be maintained regardless of the final sample size.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?

The people assessing the outcomes
Intervention assignment
Other design features
Not Applicable
Type of endpoint(s)
Statistical methods / analysis

Recruitment status
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment in Australia
Recruitment state(s)
Recruitment postcode(s) [1] 23504 0
2000 - Sydney
Recruitment postcode(s) [2] 23505 0
4059 - Red Hill

Funding & Sponsors
Funding source category [1] 267147 0
Name [1] 267147 0
Australian Rotary Health
Address [1] 267147 0
PO Box 3455
Parramatta, NSW 2124
Country [1] 267147 0
Primary sponsor type
The University of Wollongong
Wollongong Campus
Wollongong, NSW
Secondary sponsor category [1] 266219 0
Name [1] 266219 0
University of New South Wales
Address [1] 266219 0
Country [1] 266219 0
Secondary sponsor category [2] 266220 0
Name [2] 266220 0
University of Newcastle
Address [2] 266220 0
Callaghan Campus
Callaghan, NSW
Country [2] 266220 0

Ethics approval
Ethics application status
Ethics committee name [1] 269138 0
University of Wollongong Human Research Ethics Committee
Ethics committee address [1] 269138 0
Wollongong Campus
University of Wollongong
Wollongong, NSW
Ethics committee country [1] 269138 0
Date submitted for ethics approval [1] 269138 0
Approval date [1] 269138 0
Ethics approval number [1] 269138 0

Brief summary
It is extremely common for individuals with substance abuse disorders to also have co-occurring mental health problems. Approximately 60% of participants at Australian residential rehabilitation services report a previous mental health diagnosis, with depressive disorders being the most common. Individuals with co-occurring mental health problems typically have a poorer treatment response and higher rates of relapse. Integrated treatment approaches are recommended for residential substance abuse programs, where both the person’s substance abuse and co-occurring mental health problems are concurrently addressed. However, the majority of residential substance abuse services still primarily target the person’s substance abuse problems.

One approach to improve treatment is to utilise computer-based self-help programs. Benefits of computer-based approaches to residential settings include: a) the low costs associated with delivering the intervention; b) it doesn’t require additional staff members or training; and c) participants can continue to access the program should they leave the facility early. There is a growing body of literature supporting the usefulness of computer delivered interventions for mental health problems. Additionally, computer-based interventions have been recommended as a way to improve the use of evidence based approaches within routine care. However, only limited controlled dissemination research has been conducted in this area.

The aim of the present study is to examine the effectiveness of using a computer delivered comorbidity treatment program for individuals attending long-term residential substance abuse programs. The study will be conducted as a real-world randomized trial, where the Treatment Condition will complete the computer-delivered intervention in addition to treatment as usual.
Trial website
Trial related presentations / publications
Kelly, P. J., Kay-Lambkin, F. J., Baker, A. L., Deane, F. P., Brooks, A. C., Mitchell, A., Marshall, S., Whittington, M., & Dingle, G. A. (2012). Study protocol: A randomized controlled trial of a computer-based depression and substance abuse intervention for people attending residential substance abuse treatment. BMC Public Health. doi:10.1186/1471-2458-12-113.
Public notes

Principal investigator
Name 32465 0
Dr Peter Kelly
Address 32465 0
Northfields Avenue,
School of Psychology,
University of Wollongong
NSW, Australia 2500
Country 32465 0
Phone 32465 0
+61 2 42 39 23 82
Fax 32465 0
Email 32465 0
Contact person for public queries
Name 15712 0
A/Prof Peter Kelly
Address 15712 0
School of Psychology
Wollongong Campus
University of Wollongong
NSW, 2522
Country 15712 0
Phone 15712 0
+61 2 42 39 2382
Fax 15712 0
Email 15712 0
Contact person for scientific queries
Name 6640 0
A/Prof Peter Kelly
Address 6640 0
School of Psychology
Wollongong Campus
University of Wollongong
NSW, 2522
Country 6640 0
Phone 6640 0
+61 2 42 39 2382
Fax 6640 0
Email 6640 0

No information has been provided regarding IPD availability
Summary results
Have study results been published in a peer-reviewed journal?
Other publications
Have study results been made publicly available in another format?
Results – basic reporting
Results – plain English summary